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Abstract
Type I interferons (IFNs) are cytokines that orchestrate diverse immune responses to viral and bacterial infections. Although
typically considered to be most important molecules in response to viruses, type I IFNs are also induced by most, if not all,
bacterial pathogens. In this study, we addressed the role of type I IFN signaling during Brucella abortus infection, a
facultative intracellular bacterial pathogen that causes abortion in domestic animals and undulant fever in humans. Herein,
we have shown that B. abortus induced IFN-b in macrophages and splenocytes. Further, IFN-b induction by Brucella was
mediated by IRF3 signaling pathway and activates IFN-stimulated genes via STAT1 phosphorylation. In addition, IFN-b
expression induced by Brucella is independent of TLRs and TRIF signaling but MyD88-dependent, a pathway not yet
described for Gram-negative bacteria. Furthermore, we have identified Brucella DNA as the major bacterial component to
induce IFN-b and our study revealed that this molecule operates through a mechanism dependent on RNA polymerase III to
be sensed probably by an unknown receptor via the adaptor molecule STING. Finally, we have demonstrated that IFN-abR
KO mice are more resistant to infection suggesting that type I IFN signaling is detrimental to host control of Brucella. This
resistance phenotype is accompanied by increased IFN-c and NO production by IFN-abR KO spleen cells and reduced
apoptosis.
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Introduction
Brucella abortus is a Gram-negative, facultative intracellular
coccobacillus which causes brucellosis in humans and in cattle.
In humans B. abortus causes undulant fever, endocarditis, arthritis
and osteomyelitis and, in animals, it leads to abortion and
infertility resulting in serious economic losses [1,2]. The protective
response against B. abortus infection requires CD4
+ and CD8
+ T
lymphocytes, Th1-type cytokines such as interferon-gamma (IFN-
c) and tumor necrosis factor (TNF-a), and activated macrophages
and dendritic cells [3–5]. The innate immune system is the first
line of defense mechanisms that protect hosts from invading
Brucella. It begins with the recognition of pathogen-associated
molecular patterns (PAMPs) by pattern recognition receptors
(PRRs). The best characterized PRRs known to recognize Brucella
PAMPs are the Toll-like receptors (TLRs), which are transmem-
brane receptors that sense lipids, lipoproteins, proteins and nucleic
acids [6–8]. This recognition activates intracellular signaling
pathways that culminate in the induction of inflammatory
cytokines, chemokines, interferons and upregulation of co-
stimulatory molecules [9]. It has been shown that Brucella is
recognized by several TLR-associated pathways triggering proin-
flammatory responses that impact both the nature and the
intensity of the immune response [10].
Since their discovery nearly 50 years ago, IFNs have been
described as products of virus-infected cells capable of inducing
an antiviral state in neighbouring cells through a paracrine
signaling [11]. Conversely, type I IFNs have been traditionally
assigned a minor role in antibacterial host defenses [12].
Recently, however, conserved bacterial products, such as LPS
and DNA, were found to activate distinctive signal transduction
pathways compared to those activated by viruses and lead to high
levels of type I IFN production [13]. Moreover, the role of type I
IFN in antibacterial defenses is still controversial. The induction
of type I IFN during some intracellular Gram-positive bacterial
pathogens infection appears to be detrimental to the host. In IFN-
a/b-receptor KO mice infected with Listeria monocytogenes the titer
of bacteria recovered from the liver and spleen was 10
2–10
3-fold
lower than in the wild type mice [14,15]. Another intracellular
bacterium that induces high levels of type I IFN is a hypervirulent
PLoS ONE | www.plosone.org 1 August 2011 | Volume 6 | Issue 8 | e23135strain of Mycobacterium tuberculosis. It was showed that mice
infected with this M. tuberculosis strain died at faster rate due to
failure to induce Th1 cellular mediated immunity [16]. The lack
of development of Th1 immunity in response to this bacterium
appears to be associated with increased induction of type I IFNs.
In the Chlamydia muridarum infection model, IFN-a/b-receptor
KO mice were found to be more resistant to infection than wild
type mice [17]. The observed susceptibility of the wild type mice
to C. muridarum was due to the induction of type I IFNs resulting
in enhanced apoptosis of lung infiltrated macrophages. However,
there are other bacterial infection models such as Legionella
pneumophila, Bacillus anthracis and Group B Streptococcus where the
function of type I IFNs are protective for host suppressing
bacterial invasion due the enhancement of IFN-c/NO produc-
tion [18–20].
Although TLRs are the best characterized innate receptors
related to recognize and to trigger a signaling for an efficient
response against pathogens, they are only a piece of a broad
repertoire of molecules capable to induce cellular signaling to
fight against a microbial infection. Among them, the cytosolic
receptors which are capable of sensing pathogen nucleic acids
released from lysed bacteria or from bacterial secretion system
during infection have been intensively studied [13]. Regarding
that, retinoic acid inducible gene I (RIG-I), melanoma differen-
tiation associated gene 5 (MDA5) and laboratory of genetics and
physiology 2 (LGP2), members of RLR family were reported to
recognize viral RNA and trigger an anti-viral response inducing
type I IFN [21]. Few reports are available describing the role of
RLR receptors recognizing bacterial RNAs. Since bacterial
mRNAs are not capped and can contain 59 triphosphate, they
can induce type I interferon throughout RIG-I signaling [22]. In
independent studies, Ablasser and colleagues [23], and Chiu et al.
[24] demonstrated that RNA polymerase III transcribes highly
AT-rich bacterial DNA present in the host cell cytosol to 59-
triphosphate RNA which is preferentially recognized by RIG-I
[25]. The downstream signaling mediated by RIG-I requires the
protein adaptor IPS-1 (MAVS, Cardiff or VISA), which
coordinates the activation of IRF3/7, NF-kB and MAP kinases
[21]. In addition to IPS-1, another molecule termed stimulator of
interferon genes (STING) has been identified as an adaptor
required by RIG-I to induce type I IFN in response to Listeria
monocytogenes and C. muridarum [26,27]. Furthermore, other groups
have attempted to find a yet undefined bacterial DNA sensor that
can signal through a TLR9-independent and RLR-independent
pathways [28,29].
In this study, we have shown that B. abortus induced IFN-b in
macrophages and splenocytes. To gain insights into the molecules
involved in IFN-b synthesis we defined that Brucella DNA is a
potent stimulus for this cytokine expression. In addition, IFN-b
induced by Brucella requires IRF3 and STAT1 phosphorylarion at
tyrosine 701. Further, Brucella or its DNA induces IFN-b
independent of TLRs and TRIF signaling but dependent on
MyD88. Regarding, the putative cytosolic sensors involved in
Brucella DNA recognition, we demonstrated here that RNA
polymerase III and the adaptor molecule STING are critical
components required for IFN-b signaling pathway. Additionally,
we have demonstrated that IFN-abR KO mice are more resistant
to infection suggesting that type I IFN signaling is detrimental to
host control of Brucella. This resistance phenotype seems to be
related to increased IFN-c and NO production by IFN-abRK O
spleen cells and reduced apoptotic profile. In summary, these
findings propose a novel IFN-b pathway induced by a Gram-
negative bacterial DNA that requires the engagement of RNA
polymerase III and STING.
Results
Brucella induces IFN-b in macrophages and splenocytes
To investigate whether B. abortus induces type I IFN,
macrophages or spleen cells were exposed to bacteria and IFN-b
was measured at several time points. Wild type (129Sv/Ev) or
IFN-abR KO macrophages as well as splenocytes infected with B.
abortus strain 2308 displayed increased expression of IFN-b as
measured by ELISA or real-time RT-PCR, respectively. In
infected BMDM, maximal IFN-b responses were observed at
72 hrs post-infection (Fig. 1A). Curiously, IFN-abR KO macro-
phages produced greater amounts of IFN-b compared to the wild
type cells. This process is probably a compensatory mechanism
due to the lack of the type I IFN receptor. Furthermore, fifteen
days after infection IFN-b transcripts were measured in splenocytes
by real-time RT-PCR (Fig. 1B) and IFN-b production by ELISA
(Fig. 1C). Similarly to what was observed in macrophages, IFN-b
was higher in IFN-abR KO spleen cells compared to 129Sv/Ev
mice. These findings demonstrate that B. abortus induces IFN-b
production in immune cells.
Absence of type I IFN signaling enhances host protection
to Brucella infection
To study the role of type I IFN in host response against Brucella
infection, we infected IFN-abR KO and 129Sv/Ev mice with
1610
6 B. abortus strain 2308. Comparison of colony-forming units
(cfu) recovered from the spleens of IFN-abR KO and 129Sv/Ev
mice fifteen days post-infection showed reduced bacterial numbers
in type I IFN receptor deficient mice (Figure 2A). Similar findings
demonstrating the detrimental role of type I IFN signaling to host
control of bacterial infection were also observed for L. monocytogenes,
Tropheryma whipplei and C. muridarum [14,15,17,30]. Since Brucella
mutant to the type IV secretion system (T4SS, virB mutant) fails to
elicit IFN-induced gene expression during early infection [31], we
decided to also evaluate the role of T4SS during Brucella infection
in IFN-abR KO mice. As observed in Brucella strain S2308
expressing T4SS infection, virB mutant showed reduced cfu counts
in type I IFN receptor deficient mice compared to the wild type
(Figure 2A). However, the reduced numbers of virB mutant cfu
found in both mouse strains compared to parental strain 2308 is
probably due to already described reduced virulence of this
mutant [32]. These results demonstrated that T4SS plays no role
in resistance of IFN-abR KO mice to B. abortus infection in vivo.
To address whether increased resistance observed in IFN-abR
KO mice was associated with pro-inflammatory mediators, we
measured IFN-c, IL-17 and NO in spleen cells of type I receptor
deficient mice and control animals. Elevated production of IFN-c
and NO in Brucella-primed splenocytes in vitro stimulated with live
strain 2308 was observed in receptor-deficient mice compared to
the wild type (Figure 2B and 2C). Additionally, no difference in IL-
17 production was observed in IFN-abR KO compared to 129Sv/
Ev mice (Figure S1). Together, these findings suggest that type I
IFN signaling induced by Brucella is detrimental to infection and
regulate inflammatory components required for host protection.
Brucella abortus-induced splenic apoptosis is dependent
on type I IFN signaling
One of the hallmark effects mediated by type I IFNs is the
induction of apoptosis in infected cells which has been shown in
the L. monocytogenes model to be associated with enhanced infection
[14]. To assess whether B. abortus can also induce apoptosis, mice
were infected and splenocyte apoptosis was determined by
TUNEL assay and by flow cytometry using annexin V. We have
observed increased apoptosis in the splenic tissue of 129Sv/Ev
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PLoS ONE | www.plosone.org 2 August 2011 | Volume 6 | Issue 8 | e23135infected mice compared to uninfected controls as indicated by
TUNEL+ cells (Figure 3A and 3B). However, Brucella-infected
IFN-abR KO mouse spleens exhibited a drastic reduction in
splenic apoptosis compared to wild type controls. The results
presented in Figure 3B as % of TUNEL-positive cells were
determined by counting TUNEL+ cells in mouse spleen sections.
These results were also confirmed by the percentage of Annexin
V
+/7AAD
2 cells detected in spleens. IFN-abR KO splenocytes
infected with Brucella did not show enhancement in the number of
Annexin V
+/7-AAD
2 cells compared to uninfected controls;
however, it was observed in 129Sv/Ev mice (Figure 3C). In order
to detect the type I IFN-stimulated genes (ISGs) up-regulated in
spleens during Brucella infection, we measured the expression of
TRAIL, IP-10 and IRF7 by real-time RT-PCR. Figure 3D shows
that only the proapoptotic gene TRAIL was significantly up-
regulated in Brucella-infected splenocytes from wild type mice and
it was highly suppressed in IFN-abR KO mouse spleens. For IP-10
and IRF7, we did not observe statistically significant difference in
gene expression in receptor-deficient mice compared to the wild
type (data not shown). These results demonstrate that B. abortus-
induced apoptosis in vivo is largely dependent on type I IFN
signaling.
Induction of IFN-b and TRAIL expression requires IRF3
The transcription factor IRF3 has been shown to mediate the
induction of IFN-b gene in response to pathogens and TLR
signaling [33]. To determine whether induction of IFN-b by B.
abortus also involves IRF3, Raw 264.7 macrophages were treated
with siRNA 1075 specific for IRF3 and the cells infected with
Brucella S2308 or stimulated with poly I:C as positive control.
Transfection of IRF3-specific siRNA in Raw 264.7 cells resulted in
a dramatic reduction of IFN-b expression levels (90%) as
determined by real-time RT-PCR (Figure 4A). Inhibition of
IRF3 led to a profound reduction of IFN-b transcripts following B.
abortus or poly I:C stimulation, compared to siRNA non-treated
cells. This result identifies IRF3 as a component of the signaling
pathway leading to type I IFN induction by B. abortus-infected
macrophages. Similarly to what was observed for IFN-b, IRF3
inhibition resulted in a dramatic reduction in TRAIL expression
(95%) in Brucella-infected macrophages (Figure 4B). Taken
together, these findings demonstrated that IRF3 is a critical
transcriptional regulator of IFN-b and TRAIL gene expression
during B. abortus infection.
Brucella DNA induces IFN-b and TRAIL expression in
macrophages
Recent evidences suggest that induction of type I IFN by
bacteria is mediated by nucleic acids from different pathogens
[34]. In order to identify specific Brucella components involved in
IFN-b expression, we have tested Brucella DNA, Omp19 (outer-
membrane lipoprotein) or LPS. As observed in Figures 5A and
5B, Brucella DNA induces high levels of IFN-b and TRAIL
expression in 129Sv/Ev BMDM. In contrast, reduced transcripts
for TRAIL but not for IFN-b were observed in DNA-exposed
macrophages from IFN-abR KO mice. These results lead us to
conclude that IFN-b expression induced by Brucella or its DNA
occurs independently of type I IFN receptor signaling. Brucella
Omp19 did not induce the expression of IFN-b and Brucella LPS
induced very low levels of this cytokine mRNA (Figure S2).
Treatment of Brucella DNA with DNase I abolished the
stimulatory activity, a result suggesting that the DNA is the main
ligand for an unknown receptor responsible for triggering the
IFN-b response.
STAT1 phosphorylation induced by Brucella or its DNA is
dependent on type I IFN signaling
Once produced type I IFNs can signal in an autocrine and
paracrine manner leading to the phosphorylation-dependent
activation of STAT1 through type I IFN receptor [35]. To
determine whether B. abortus or its DNA induces STAT1
activation, we performed western blot analysis using specific
antibodies targeting STAT1 phosphorylated at tyrosine 701 in
Figure 1. Brucella induces IFN-b in macrophages and spleen
cells. (A) BMDM from 129Sv/Ev or IFN-abR KO mice were infected with
B. abortus strain S2308 (10
3 bact/cell) and IFN-b was measured by ELISA
at 24, 48 and 72 hours. (B) Spleen cells from B. abortus infected mice at
fifteen days post-infection were isolated and total RNA was harvested
and mRNA levels of IFN-b were determined by real-time RT-PCR and
normalized to b-actin. (C) Spleen cells from B. abortus infected mice at
fifteen days post-infection were cultured with 10
2 bacteria/cell for
48 hrs and IFN-b was detected by ELISA. Error bars represent the mean
6SD. Similar results were obtained in two-independent experiments.
Statistically significant difference of IFN-b levels from IFN-abR KO mice
compared to wild type is denoted by an asterisk (p,0.05).
doi:10.1371/journal.pone.0023135.g001
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phosphorylation after B. abortus or its DNA stimulation was
evidenced at 6 hrs but not at 12 hrs in 129Sv/Ev mice. In
contrast, STAT1 phosphorylation was completely absent when
IFN-abR KO BMDM were infected with Brucella or activated with
its DNA.
Brucella-induced IFN-b expression is TLR- and TRIF-
independent but MyD88-dependent
To determine the role of TLRs, TRIF and MyD88 signaling in
IFN-b expression elicited by Brucella or its DNA, real-time RT-
PCR was performed in TLR2, TLR4, TLR9, TRIF and MyD88
KO BMDM. As shown in Figure 7A and Figure 8A, IFN-b
expression by B. abortus strain 2308 or its DNA is independent of
TLR recognition and the adaptor molecule TRIF but dependent
on MyD88 signaling. Our results demonstrated that in contrast to
BMDM from wild type, TLRs KO or TRIF KO, IFN-b
expression was totally abrogated in MyD88 BMDM infected with
Brucella or stimulated with its DNA. To confirm these results we
performed ELISA to measure IFN-b and we obtained similar
results as observed for real-time PCR (Figure 7B and 8B). These
findings suggest that other receptor signaling through MyD88
different from TLR2, TLR4 or TLR9 is involved in type I IFN
response during B. abortus infection. Since the role of TRIF
signaling during B. abortus infection in vivo has not been reported,
we decided to determine the function of this adaptor molecule in
host control of this bacterial infection. As shown in Figure 8C,
fifteen days following infection with 1610
6 cfu of B. abortus strain
2308, bacterial numbers were similar in spleens of wild type and
TRIF KO mice. Therefore, these results suggest that TRIF is not
involved in the host control of B. abortus infection.
Brucella-induced IFN-b is dependent on RNA Polymerase
III and STING
In addition to surface- or endosome-localized innate receptors,
host cells also express several cytosolic sensors that induce type I
IFN in response to nucleic acid ligands such as RNA and DNA
[13]. However, the mechanisms by which bacteria stimulate
cytosolic sensors are under investigation. Recently, Chiu et al. [24]
reported that DNA could stimulate a RNA sensor. In this
mechanism, RNA polymerase III transcribes cytosolic DNA
thereby generating RNA ligands for RIG-I like receptors (RLR).
In addition to the RNA polymerase III pathway, mouse and
human cells have other cytosolic DNA sensors driving the
transcriptional activation of type I IFN [29]. Further, STING
(stimulator of interferon genes) was recently identified as a
downstream signaling adaptor required for IFN-b induction in
response to cytosolic DNA [26]. In order to address whether B.
abortus- or bacterial DNA-induced IFN-b expression in Raw 264.7
macrophages was dependent on RNA polymerase III or STING, a
Figure 2. Bacterial burden, IFN-c and NO production in Brucella-infected 129Sv/Ev and IFN-abR KO mice. Five 129Sv/Ev or IFN-abRK O
mice were infected i.p. with a dose of 10
6 CFU of B. abortus strain S2308 or DvirB mutant. (A) Spleens were harvested at fifteen days post-infection,
and the number of CFU in disrupted tissue was determined by 10-fold serial dilution and plating. (B) Spleen cells from B. abortus S2308 infected mice
were cultured with 10
2 bacteria/cell, ConA (5 mg/ml) or medium alone for 72 hrs and IFN-c was detected by ELISA. (C) Regarding nitric oxide, nitrite
concentration was measured by Griess reaction (mM) using the same stimuli described for IFN-c measurements except the use of E. coli LPS (1 mg/ml)
as positive control. Error bars represent the mean 6SD. Similar results were obtained in three-independent experiments. Statistically significant
difference from IFN-abR KO mice compared to wild type is denoted by an asterisk (p,0.05).
doi:10.1371/journal.pone.0023135.g002
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technology for STING was used. As demonstrated in Figure 9, the
use of RNA polymerase III inhibitior (ML-60218) at 0.1 or
1.0 mM of concentration dramatically reduced IFN-b mRNA
during Brucella infection of macrophages (83%) or during
stimulation with its DNA (100%). This finding demonstrates that
RNA polymerase III-dependent pathway plays an important role
in IFN-b induction by Brucella, probably transcribing bacterial
DNA to be recognized by a yet unknown receptor. Furthermore,
we tested the role of STING in Brucella-induced IFN-b expression.
By real-time RT-PCR analysis, it can be observed that by silencing
STING resulted in a significant decrease in IFN-b mRNA levels
during B. abortus infection of macrophages (55%) or upon
macrophage stimulation with bacterial DNA (93%) compared to
siRNA non-treated cells. This result demonstrates that STING is a
crucial adaptor molecule of host cell involved in IFN-b induction
by Brucella.
Discussion
Although type I IFNs are well known to induce a robust
antiviral host response, the role of type I IFNs in response to
bacterial infection is variable and even it is sometimes detrimental
to the host. For instance, IFN-abR KO mice exhibit lower L.
monocytogenes burdens in the liver and spleen as compared with wild
type mice [14,15,36]. Type I IFN signaling is also detrimental to
the clearance of M. tuberculosis infection from the spleen [37] and
the lung [38]. Furthermore, type I IFN impairs clearance of
Chlamydia from the genital tract and lungs [17,39], and it is
detrimental to the host during infection with T. whipplei [30]. In
contrast, type I IFN is crucial for host resistance to some bacterial
infections. For example, IFN-abR KO mice exhibit decreased
survival and increased bacterial burdens upon infection with
Group B Streptococcus, Streptococcus pneumoniae and Escherichia coli
[20]. Additionally, type I IFN also plays a role in restricting L.
Figure 3. B. abortus induced-apoptosis depends on type I IFN signaling. (A) Spleens from 129Sv/Ev or IFN-abR KO mice after two-weeks of
infection with B. abortus were removed and tissue sections were analyzed to determine the apoptotic cells by TUNEL assay as described in material
and methods. (B) This graph demonstrates the % of TUNEL-positive cells shown in panel A. (C) Annexin V
+/7-AAD
2 analysis of spleen cells of Brucella-
infected 129Sv/Ev or IFN-abR KO mice performed by flow cytometry. (D) The expression levels of TRAIL were measured by real-time PCR in spleens of
Brucella-infected 129Sv/Ev or IFN-abR KO mice. Similar results were obtained in two-independent experiments. Error bars represent the mean 6SD.
Statistically significant difference from Brucella-infected and uninfected mice is denoted by an asterisk and between IFN-abR KO mice compared to
wild type is denoted by two asterisks (p,0.05).
doi:10.1371/journal.pone.0023135.g003
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IFN-abR KO mice to these infections has been correlated with
reduced TNF-a and IFN-c production. In response to Francisella
tularensis, type I IFN signaling has also been observed to induce the
expression of inflammasome components such as IL-1b and IL-18
[41]. Due to the complex cytokine circuit involving type I IFNs,
the mechanisms by which the immunomodulatory effects of these
IFNs are regulated are only beginning to be understood [42].
Regarding type I IFNs induced by B. abortus infection, the first
demonstration that Brucella induces IFN-a was reported by Huang
et al [8] using heat-killed bacteria (HKBa). IFN-a was detected in
serum of wild type mice injected with HKBa and the level was
markedly reduced in the TLR9 KO mice serum, demonstrating
that HKBa induces IFN-a in a TLR9-dependent manner.
Additionally, Salcedo et al [43] have shown that Brucella is able
to induce IFN-b in dendritic cells. In this study, we have
demonstrated that Brucella induces IFN-b in BMDM and
splenocytes from wild type and IFN-abR KO mice. Furthermore,
we demonstrated that type I IFN signaling is detrimental to host
control of B. abortus infection since low numbers of bacterial cfu
Figure 4. IRF3-dependent expression of IFN-b and TRAIL upon Brucella abortus infection. Raw 264.7 macrophages were treated with non-
targeting control siRNA, a specific-targeting IRF3 (si1075) or non-treated control (NT). Total mRNA was obtained after 24 hrs stimulation with B.
abortus S2308 (10
3 bact/cell) or poly I:C (10 mg/ml) as positive control. Next, IFN-b (A) and TRAIL (B) transcript levels were measured by real-time RT-
PCR. Error bars represent the mean 6SD of samples assayed in triplicate. A representation of at least three experiments is shown. Statistically
significant difference from cells treated with si1075 versus non-treated cells is denoted by an asterisk, from Brucella-infected cells treated with si1075
versus non-treated (NT) cells by two asterisks and from poly I:C stimulated cells treated with si1075 versus non-treated cells by three asterisks
(p,0.05).
doi:10.1371/journal.pone.0023135.g004
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control animals. In contrast to our findings, Roux et al [31] have
shown that Brucella cfu recovered from IFN-abR KO mice
compared to parental BALB/c mice showed no significant
differences during the first 4 weeks of infection. The differences
observed in these studies may be related to the mouse strain used,
since we have worked with 129Sv/Ev background and Roux et al
[31] have used BALB/c mice. Further, the virB T4SS plays a
crucial role in Brucella intracellular replication [32]. Since the virB
T4SS system secretes effector proteins able to modify host cell
functions, we also investigated whether virB was involved in
Brucella host control in IFN-abR KO mice. As demonstrated in
Figure 2, similarly to observed to virulent strain 2308, IFN-abR
KO mice infected with Brucella DvirB mutant showed reduced
bacterial burden compared to wild type mice.
The in vivo mechanisms by which type I IFN signaling increases
host susceptibility to bacterial infection remain unclear. One
possible mechanism is that induction of type I IFN by Listeria was
shown to suppress macrophage activation by reducing the ability
to respond to IFN-c down-regulating IFN-cR expression [44].
Mice lacking IFN-abR have increased expression of IFN-cR and
their reduced susceptibility to L. monocytogenes infection is
dependent on IFN-c. Herein, we observed that splenocytes from
Brucella-infected IFN-abR KO mice produced higher amounts of
IFN-c and NO, two critical components to host control of this
bacterial infection [45]. Therefore, this mechanism of antagonistic
cross-talk between type I and II IFNs might be an important
aspect involved in IFN-abR KO mice resistance to Brucella
infection. Additionally, abundant type I IFN predisposes lympho-
cytes to apoptosis during Listeria infection and it has a negative
effect on bacterial handling in the mouse [46]. In this study, we
have observed that Brucella-infected 129Sv/Ev mice induced
higher percentage of apoptotic spleen cells as demonstrated by
Figure 5. Brucella DNA is the major component responsible for IFN-b and TRAIL expression in macrophages. BMDM from 129Sv/Ev or
IFN-abR KO mice were infected with B. abortus strain S2308 (10
3 bact/cell), stimulated with Brucella DNA (1 mg/5610
5 cells), Brucella DNA treated with
DNAse (0.2 U/mg DNA), poly I:C (10 mg/ml) or medium alone. After that, total RNA was harvested and mRNA levels of IFN-b (A) and TRAIL (B) were
determined by real-time RT-PCR and normalized to b-actin. Error bars represent the mean 6SD of samples assayed in triplicate. Similar results were
obtained in two-independent experiments. Statistically significant difference of IFN-b or TRAIL levels from stimulated macrophages versus non-
stimulated cells is denoted by an asterisk, from IFN-abR KO mouse macrophages compared to wild type is denoted by two asterisks and from Brucella
DNA compared to Brucella DNA treated with DNAse with three asterisks (p,0.05).
doi:10.1371/journal.pone.0023135.g005
Figure 6. STAT1 phosphorylation induced by B. abortus or its
DNA is impaired in mice lacking IFN-ab receptor. BMDMs from
wild type (129Sv/Ev) and IFN-abR KO mice were stimulated for 6 and
12 hrs with B. abortus S2308 (10
3 bact/cell) or Brucella DNA (1 mg/5610
5
cells). Cell lysates were analyzed by immunoblotting using anti-STAT1
and anti-phospho-STAT1 at tyrosine 701 residue. One experiment is
shown representative of three.
doi:10.1371/journal.pone.0023135.g006
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+/7-AAD
2.
Conversely, mice lacking IFN-abR were more resistant to Brucella
infection and displayed less apoptotic lesions as well as reduced
expression of pro-apoptotic gene TRAIL than their wild type
counterparts. We speculate here that type I IFN signaling
enhances immune cells apoptosis; therefore, causing the increased
susceptibility to Brucella. However, further experiments are
required to support this hypothesis. Another possible mechanism
by which type I IFN enhances host susceptibility to bacterial
infection, relates to the observation that these cytokines stimulate
the production of IL-27, a molecule that strongly suppresses IL-
17A production [47]. IL-17A produced by cd T cells appears to
play an important role in restricting Listeria replication by
orchestrating neutrophil responses [48]. In fact, IFN-abRK O
mice induced more IL-17A in response to Francisella and Listeria
infections [49]. We have investigated here whether Brucella
regulates IL-17A production and we found that in bacteria-
infected splenocytes the levels of IL-17A in IFN-abR KO mice
were similar to wild type spleen cells (Figure S1). This result ruled
out the possibility that lack of type I IFN signaling could enhance
IL-17A production and host resistance to Brucella infection.
Following stimulation with bacterial components, the constitu-
tively expressed IRF3 is phosphorylated in the cytoplasm,
dimerizes and then translocates into the nucleus to induce the
transcription of type I IFN [50]. We therefore, determined the role
of IRF3 in IFN-b and TRAIL expression in Raw 264.7
macrophages using siRNA technology. IFN-b and TRAIL
expression were dramatically reduced when IRF3 transcription
factor was silenced, identifying IRF3 as an important component
of the signaling pathway leading to type I IFN induction by
Figure 7. Brucella-induced IFN-b expression requires MyD88 signaling independently of TLR2, TLR4, and TLR9. (A) BMDM from TLR2,
TLR4, TLR9 and MyD88 KO and wild type (C57BL/6) mice were infected with B. abortus strain S2308 (10
3 bact/cell), stimulated with Brucella DNA
(1 mg/5610
5 cells), Brucella DNA treated with DNAse (0.2 U/mg DNA), poly I:C (10 mg/ml) or medium alone. After 24 hours, total RNA was harvested
and mRNA levels of IFN-b were determined by real-time RT-PCR and normalized to b-actin. Statistically significant difference of IFN-b levels from
stimulated macrophages versus non-stimulated cells is denoted by an asterisk, from MyD88KO compared to the other mice by two asterisks and from
Brucella DNA compared to Brucella DNA treated with DNAse with three asterisks (p,0.05). (B) BMDM cells from TLR9 KO, MyD88 KO and wild type
(C57BL/6) were infected with B. abortus strain S2308 (10
3 bact/cell), stimulated with Brucella DNA (1 mg/5610
5 cells), poly I:C (10 mg/ml) or medium
alone were cultured for 24 hrs and IFN-b was detected by ELISA. Statistically significant difference of IFN-b levels from stimulated macrophages
versus non-stimulated cells is denoted by an asterisk, from MyD88KO compared to the other mice by two asterisks. Error bars represent the mean
6SD of samples assayed in triplicate. Similar results were obtained in three-independent experiments.
doi:10.1371/journal.pone.0023135.g007
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abortus induces IFN-inducible genes via a type I IFN autocrine loop
after engagement of the type I receptor. Thus, we monitored
STAT1 activation, one outcome of IFN secretion and type I IFN
receptor engagement. Brucella-infected wild type BMDM showed
an increased in STAT1 tyrosine 701 at 6 hrs post-infection. In
contrast, STAT1 tyrosine 701 phosphorylation was totally
abrogated in IFN-abR KO macrophages infected with Brucella.
Collectively, these findings demonstrate that B. abortus induction of
IFN-b occurs through an IRF3-dependent pathway and that
subsequent STAT1 activation via IFN-abR leads to a positive
feedback loop involved in BMDM response to Brucella.
Figure 8. TRIF-mediated signaling is dispensable for IFN-b expression induced by B. abortus or its DNA. (A) BMDMs from TRIF KO and
wild type (129Sv/Ev) mice were infected with B. abortus strain S2308 (10
3 bact/cell), stimulated with Brucella DNA (1 mg/5610
5 cells), Brucella DNA
treated with DNAse (0.2 U/mg DNA), poly I:C (10 mg/ml) or medium alone. After 24 hours, total RNA was harvested and mRNA levels of IFN-b were
determined by real-time PCR and normalized to b-actin. Error bars represent the mean 6SD of samples assayed in triplicate. Similar results were
obtained in three-independent experiments. Statistically significant difference of IFN-b levels from stimulated macrophages versus non-stimulated
cells is denoted by an asterisk, from wild type mice to TRIF KO with two asterisks and from Brucella DNA compared to Brucella DNA treated with
DNAse with three asterisks (p,0.05). (B) BMDM cells from TRIF KO and wild type (129Sv/Ev) were infected with B. abortus strain S2308 (10
3 bact/cell),
stimulated with Brucella DNA (1 mg/5610
5 cells), poly I:C (10 mg/ml) or medium alone were cultured for 24 hrs and IFN-b was detected by ELISA.
Statistically significant difference of IFN-b levels from stimulated macrophages versus non-stimulated cells is denoted by an asterisk, from TRIF KO
compared to the wild type mice by two asterisks. Error bars represent the mean 6SD of samples assayed in triplicate. (C) Five 129Sv/Ev and TRIF KO
mice were infected i.p. with a dose of 10
6 CFU of B. abortus strain S2308. Spleens were harvested at fifteen days post-infection, and the number of
CFU in disrupted tissue was determined by 10-fold serial dilution and plating. Similar results were obtained in three-independent experiments.
doi:10.1371/journal.pone.0023135.g008
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by Brucella DNA, the lipoprotein Omp19 and its LPS. Our data
supports that Brucella DNA is a major bacterial component to
induce IFN-b in BMDM. Regarding TLR recognition of Brucella,
we and others have shown previously that TLR2, TLR4 and
TLR9 recognize bacterial components and induce pro-inflamma-
tory cytokine production [6–8]. More recently, we have shown
that the MyD88 adaptor molecule is crucial to host control against
Brucella infection [9]. In this study, we aimed to examine the role of
TLRs and their contribution to the Brucella-induced IFN-b
response. Overall, the fact that expression of IFN-b was
unimpaired in TLR2, TLR4 and TLR9 KO BMDM during
infection strongly indicated that Brucella- or its DNA-induced IFN-
b expression occurs mostly independent of TLRs. Surprisingly,
type I IFN expression by Brucella or its DNA was dependent on
MyD88 in BMDM. A pathway involving MyD88 and an
unknown PRR recognizing various Gram-positive bacteria such
as Streptococcus and Bacillus anthracis has been previously reported
[51,52]. However, to the best of our knowledge, activation of a
MyD88-dependent, TLR2/TLR4/TLR9-independent signaling
pathway is quite unique in Gram-negative bacteria. Recently,
Lapaque et al [53] have reported that Brucella-induced IRGs
expression (Irga6 and Irgm3) requires type I IFN production.
Similarly to our findings, these authors revealed that Irga6 and
Irgm3 induction by B. abortus is MyD88-dependent but TLR2/
TLR4/TLR5/TLR9-independent. Since the adaptor molecule
TRIF is involved in type I IFN production, we also decided to
investigate whether Brucella could induce IFN-b expression through
TRIF [54]. As shown in Figure 8A, Brucella or its DNA induces
IFN-b expression in a TRIF-independent manner. Additionally,
we addressed whether the adaptor molecule TRIF was involved in
Brucella infection in vivo. Our results demonstrated that TRIF
played no role in host control of B. abortus.
Brucella enters the host cell, prevents fusion of the phagosome
with the lysosome by altering the intracellular traffic of the early
phagosome vesicle [55] being located in structures that resemble
the endoplasmic reticulum [56]. Therefore, DNA from dead
Brucella is available in this endoplasmic reticulum-like organelle
and/or escape to the cytosol compartment being available to bind
to a cytosolic DNA sensor. Additionally, Brucella abortus expresses
the virB T4SS that plays a crucial role in the bacterial replication
[32]. Bacteria use type IV secretion systems for genetic exchange
and to deliver effector molecules to eukaryotic target cells. In
addition to DNA from dead Brucella that can be released in the
BCV (Brucella-containing vacuole) and/or escape to the cytosol
compartment being available to bind to a cytosolic DNA sensor,
there is the possibility of the Brucella DNA be released by the
translocation through the type IV secretion system. Even though,
the virB was not involved in host control of Brucella in IFN-abR
KO mice, the role of the type IV secretion system in releasing
bacterial DNA in the cytosol remains to be fully characterized
during B. abortus infection. Furthermore, the cellular sensors that
detect DNA and triggers type I IFN production have remained
largely unknown. The cytosolic receptors which are capable of
sensing pathogen nucleic acids released from lysed bacteria or
from bacterial secretion system during infection are now under
intensive investigation [13]. Regarding that, retinoic acid inducible
gene I (RIG-I), melanoma differentiation associated gene 5
(MDA5) and laboratory of genetics and physiology 2 (LGP2),
members of RLR family were reported to recognize viral RNA
and trigger an anti-viral response inducing type I IFN [21]. In this
study, our findings are consistent with the hypothesis that RNA
polymerase III detects some segments of Brucella DNA and
transcribes them into RNA ligands that induce IFN-b possibly
through the RIG-I pathway. Since, inhibition of RNA polymerase
III enzymatic activity totally abrogated IFN-b expression induced
by Brucella DNA. These results strongly suggest that RNA
polymerase III plays a key role in sensing bacterial DNA during
B. abortus infection. Furthermore, an endoplasmic reticulum
resident transmembrane protein termed STING (stimulator of
interferon genes) has been identified as an adaptor required by
RIG-I to induce type I IFN in response to L. monocytogenes and C.
muridarum [26,27]. In order to determine whether STING plays
any role in Brucella sensing, we have used siRNA technology.
siRNA silencing demonstrated that STING is also an important
mediator of IFN-b induced by Brucella or its DNA functioning
Figure 9. IFN-b expression induced by B. abortus or its DNA requires RNA polymerase III and the adaptor molecule STING. Raw 264.7
macrophages were treated with ML-60218 (RNA polymerase III inhibitor) for 10 hours and stimulated with B. abortus strain S2308 (10
3 bact/cell), with
Brucella DNA (1 mg/5610
5 cells), Brucella DNA treated with DNAse (0.2 U/mg DNA), poly I:C (10 mg/ml) and medium alone. For STING knockdown,
macrophages were treated with non-targeting control siRNA, a specif-targeting STING or non-treated control. After three hours of stimulation total
RNA was harvested and mRNA levels of IFN-b were determined by real-time RT-PCR and normalized to b-actin. Error bars represent the mean 6SD of
samples assayed in duplicate. Similar results were obtained in three-independent experiments. Statistically significant difference of IFN-b levels from
Brucella- or its DNA-stimulated cells compared to unstimulated cells is denoted by an asterisk and from non-treated (NT) macrophages compared to
siSTING or ML-60218 treated cells is denoted by two asterisks (p,0.05).
doi:10.1371/journal.pone.0023135.g009
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receptor. Since STING was found to basally reside in the
endoplasmic reticulum, similarly to Brucella, this cell compartment
would be an important site that facilitates STING to signal during
this bacterial infection. A recent study demonstrated that the IFN-
b response to L. monocytogenes was lost in STING KO mouse
embryonic fibroblasts [26], and in mouse oviduct epithelial cells
and human cells during C. muridarum infection when siRNA was
used [27]. These findings reinforce STING as an important
component of the TLR-independent interferon response during
bacterial infection.
In summary, our study demonstrated that Brucella induces IFN-
b through IRF3 signaling pathway and activates IFN-stimulated
genes via STAT1 phosphorylation. Additionally, IFN-b expression
induced by Brucella is independent of TLRs but MyD88-
dependent, pathway not yet described for Gram-negative bacteria.
Further, being Brucella DNA a major bacterial component to
induce IFN-b, our study suggests that this molecule is transcribed
by RNA polymerase III to be sensed by an unknown receptor that
signals via STING. To the best of our knowledge, this is the first
report demonstrating that bacterial DNA can be sensed by RNA
polymerase III/STING pathway to coordinate type I IFN
production. Finally, type I IFN signaling enhances host suscepti-
bility to B. abortus infection independently of bacterial T4SS. The
mechanism involved in IFN-abR KO mice resistance is unknown
but it seems to involves enhanced IFN-c and NO production and
reduced apoptosis.
Materials and Methods
Ethics Statement
This study was carried out in strict accordance with the
Brazilian laws 6638 and 9605 in Animal Experimentation. The
protocol was approved by the Committee on the Ethics of Animal
Experiments of the Federal University of Minas Gerais (Permit
Number: CETEA89/2008).
Mice, cell culture and bacteria
IFN-abR KO mice were gifted by Dr. Luiz F. Reis (Ludwig
Institute, Sa ˜o Paulo, Brazil). TLR2, TLR4, TLR9 or TRIF KO
mice were kindly provided by Shizuo Akira from Osaka University
in Japan. The wild-type strains 129Sv/Ev or C57BL/6 mice were
purchased from the Federal University of Minas Gerais animal
facility (UFMG, Belo Horizonte, Brazil). Genetically deficient and
control mice were maintained at UFMG and used at 6–8 week of
age. Mouse RAW 264.7 macrophages (American Type Culture
Collection, ATCC Nu TIB-71) were grown in Dulbecco’s
Modified Eagle Medium (DMEM) high glucose containing 10%
FCS and 1% penicillin G sodium (100 U/ml), and streptomycin
sulfate (100 mg/ml). Bone marrow cells were obtained from
femora and tibia of mice and they were derived in macrophages
(BMDMs) as previously described [57]. B. abortus virulent strain
2308 was obtained from our own laboratory collection. The virB
mutant strain was kindly provided by Dr. Renato de Lima Santos
(UFMG, Belo Horizonte, Brazil). They were grown in Brucella
broth medium (BD-Pharmingen, San Diego, CA) for 3 days at
37uC.
Purification of genomic DNA from bacterial culture
To purify Brucella genomic DNA, a modification of the method
described by Wilson [58] was used. Briefly, cells were resuspended
in 0.5 ml of TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 8.0),
heat killed at 80uC for 15 min, and incubated at 37uC for 1 h with
0.5% sodium dodecyl sulfate and proteinase K (200 mg/ml). Cell
wall debris, denatured proteins, and polysaccharides were
removed by precipitation of the lysate with 5 M NaCl and
CTAB-NaCl solutions at 65uC for 10 min. DNA was extracted by
a standard protocol with phenol-chloroform-isoamyl alcohol,
precipitated with isopropanol, washed with 70% ethanol, and
dried. The DNA-containing pellet was reconstituted in 100 mlo f
nuclease-free water containing RNAse (50 mg/mL). The concen-
tration and purity of the DNA were determined spectrophoto-
metrically.
Infection and Brucella counts in spleens
Mice were infected i.p. with 10
6 CFU of B. abortus strain 2308.
To determine residual Brucella CFU in the spleens of mice, five
animals from each group were examined at 2 weeks after infection.
Spleens from individual animals were homogenized in PBS, 10-
fold serially diluted, and plated on Brucella broth agar (Difco, BD-
Pharmingen, San Diego, CA). Plates were incubated at 37uC and
the number of CFU was counted after 3 days as previously
described [57].
IFN-c, IFN-b, IL-17 and NO production by splenocytes
Splenocyte cultures from 129Sv/Ev or IFN-abR KO mice
were stimulated by addition of 10
2 live B. abortus strain S2308 per
cell or 1 mg/ml Escherichia coli LPS in a total volume of 200 mlo f
medium/well. Unstimulated cells were used as a negative control,
and cells stimulated with Con A (5 mg/ml; Sigma-Aldrich, St.
Louis, MO) were used as a T cell-activating control. Spleen cells
were incubated at 37uCw i t h5 %C O 2. Levels of IFN-c or IL-17
in the supernatants were measured using a commercially
available ELISA Duoset kit (R&D Systems, Minnesota, MN).
IFN-b levels were measured by Mouse Interferon-b ELISA Kit
(PBL Biomedical Laboratories, Piscataway, NJ). To assess the
amount of NO produced, spleen cell culture supernatants from
IFN-abR KO or 129 Sv/Ev mice stimulated with the same
antigens described above were assayed for accumulation of the
stable final product of NO, NO2 which was determined by the
Griess reaction. Briefly, culture supernatants (50 ml) were mixed
with 50 ml of Griess reagent (1% sulfanilamide, 0.1% naphthy-
lethyline diamine dihydrochloride and 2.5% phosphoric acid) in
triplicate in 96-well plates at room temperature for 5 min. The
OD at 550 nm was then measured. NO2 concentration was
determined by comparison with NaNO2 (Sigma, St. Louis, MO)
as a standard.
IFN-b production by BMDM and immunoblotting
BMDM cells from 129Sv/Ev, IFN-abR or TRIF KO and
C57BL/6, MyD88 or TLR9 KO animals completely differenti-
ated into macrophages on day 10 of culture were stimulated with
10
3 B. abortus strain S2308 bacteria per macrophage. The levels of
IFN-b in the supernatants of 24 hrs stimulated BMDMs were
measured by Mouse Interferon Beta ELISA Kit (PBL Biomedical
Laboratories, Piscataway, NJ). For immunoblotting analysis,
BMDM cells from IFN-abR KO or 129 Sv/Ev mice were
stimulated either with live B. abortus at 10
3 bacteria/cell or 1 mgo f
purified Brucella DNA (1 mg/5610
5 cells). After 6 or 12 hours, cells
were lysed with M-PER extraction buffer (Pierce, Rockford, IL)
containing a phosphatase inhibitor mixture (Calbiochem, Darm-
stadt, Germany). Protein extracts (30 mg) were then separated by
SDS-PAGE/NuPage system (Invitrogen Life Technologies, Carls-
bad, CA), electroblotted onto a nitrocellulose membrane, and
immunoblotted with specific antibodies for phospho-STAT1
(Y701) (1:1000; Cell Signaling, Boston, MA) or for total STAT1
(1:1000; Cell Signaling, Boston, MA). Antibody binding was
detected with HRP-conjugated anti-IgG (1:2000; Cell Signaling,
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Buckinghamshire, UK).
Real-Time RT-PCR
Splenocytes from Brucella infected and non-infected 129Sv/Ev
and IFN-abR KO mice or BMDM cells from 129Sv/Ev, IFN-
abR KO, C57BL/6, TLR2 KO, TLR4 KO, TLR9 KO, MyD88
KO and TRIF KO mice were snap-frozen and stored in 280uC
freezer until RNA isolation. Cells were homogenized in 350 mLo f
RA1 buffer and 3.5 mLo fb-mercaptoethanol (illustra
TM RNAspin
Mini RNA Isolation Kit – GE Healthcare, Buckinghamshire, UK)
and total RNA was isolated according to the manufacter’s
instruction. Reverse transcription of 1 mg from total RNA was
performed using illustra
TM Ready-To-Go RT-PCR Beads (GE
Healthcare, Buckinghamshire, UK). Real-Time RT-PCR was
conducted in a final volume of 10 mL containing the following:
SYBRH Green PCR Master Mix (Applied Biosystems, Foster City,
CA), oligo-dT cDNA as the PCR template and 20 mM of primers.
The PCR reaction was performed with ABI 7900 Real-Time PCR
System (Applied Biosystems, Foster City, CA), using the following
cycling parameters: 60uC for 10 min, 95uC for 10 min, 40 cycles
of 95uC for 15 sec and 60uC for 1 min, and a dissociation stage of
95uC for 15 sec, 60uC for 1 min, 95uC for 15 sec, 60uC for 15 sec.
Primers were used to amplify a specific 100–120-bp fragment
corresponding to specific gene targets as follows: IFN-b F: 59-
AGCTCCAAGAAAGGACGAACAT-39, IFN-b R: 59-GCCCT-
GTAGGTGAGGTTGATCT-39, TRAIL F: 59-ACCTCAGCTT-
CAGTCAGCACTTC-39, TRAIL R: 59-TGTAAGTCACAGC-
CACAGACACAG-39, b-Actin F: 59-AGGTGTGCACCTTT-
TATTGGTCTCAA-39, b-Actin R: 59-TGTATGAAGGTTTGG-
TCTCCCT-39; IRF3 F: 59-GGACTTGCACATCTCCAACA-39,
IRF3 R: 59-TTGCTCCACGTAGGGACAAT-39, STING F: 59-
CCTAGCCTCGCACGAACTTG-39, STING R: 59-CGCA-
CAGCCTTCCAGTAGC-39, IP10 F: 59-CCTGCCCACGT-
GTTGAGAT-39, IP10 R: 59-TGATGGTCTTAGATTCCG-
GATTC-39, IRF7 F: 59-CGCGGCACTAACGACAGGCGAG-
39, IRF7 R: 59-GCTGCCGTGCCCGGAATTCCAC-39. All data
is presented as relative expression units after normalization to the
b-actin gene. PCR measurements were conducted in triplicate.
TdT-mediated dUTP Nick-End Labeling (TUNEL) and
Annexin V assays
Splenic tissue from infected and non-infected IFN-abRK Oo r
129 Sv/Ev mice were removed and fixed in 4% paraformaldehyde.
Four mm sections were cut and mounted onto poly-l-lysine–coated
slides. The samples were permeabilized using 0.1% Triton and
0.1% sodium citrate, and then double stranded DNA breaks were
labeled using an in situ FragEL
TM DNA Fragmentation Detection
Kit, Colorimetric - TdT Enzyme (Calbiochem, Darmstadt,
Germany) according to the manufacturer’s protocol. KS300
software contained in Carl Zeiss image analyzer was used for image
acquisition of 50 images randomly chosen from each lamina at a
microscope with 406 objective lens and scanned through micro-
camera JVC TK-1270/RGB. Then, the percentage of TUNEL
positive cells was determined. For annexin V
+ staining, splenocytes
from Brucella infected and non-infected IFN-abRK Oo r1 2 9S v / E v
mice were obtained 2 weeks after infection and they were washed
t w i c ew i t hc o l dP B Sa n dt h e nr e s s u s p e n d e di n1 6 Binding Buffer
(BD-Pharmingen, San Diego, CA). Cells were stained with PE-
annexin V
+/7-AAD
2 as recommended by the manufacturer’s
protocol (BD-Pharmingen, San Diego, CA). A minimum of 10,000
splenocyte-gated events were acquired using a FACScan apparatus
(BD-Pharmingen, San Diego, CA). FACS results were analyzed
using the FlowJo Software (Tree Star, Ashland, OR).
siRNA and RNA Polymerase III inhibition
Primer sequences for silencing mouse IRF3 (accession number
BC.050882.1) were predicted with siRNA Target Finder and
siRNA Converter (AmbionH - Applied Biosystems, Foster City,
CA) and further prepared with the Ambion Silencer
TM siRNA kit.
The primer sequences used were: AS-mIRF3-1075: 59-AAGG-
TTGTTCCTACATGTCTTCCTGTC-39, SENSE-mIRF3-1075
59-AAAAGACATGTAGGAACAACCCCTGTCTC-39.F o rs i R NA
transfections, RAW 264.7 cells were cultured in 12-well plates, and
transfections were performed using FuGENE 6 (Roche Applied
Science, Indianapolis, IN) in mixture with 2 mg of siRNA per
well. After 72 hours, the cells were stimulated with 10
3 bacteria
per cell or with 10 mg of poly:IC (InvivoGen, San Diego, CA).
Accell SMARTpool siRNA duplexes targeting mouse STING
(catalog nu E-055528), and Accell siRNA delivery media were
purchased from Dharmacon (Thermo Fischer Scientific, Lafay-
ette, CO). For STING siRNA-mediated knockdown, RAW 264.7
cells were first pretreated with the indicated siRNA or control
duplexes for 72 hours in Accell siRNA media. Then the culture
medium was replaced and the cells stimulated with 10
3 bacteria/
cell, DNA (1 mg/well) or poly I:C (10 mg/mL; InvivoGen, San
Diego, CA). Messenger RNA silencing was confirmed by
quantitative SyBR-Green RT-PCR. Briefly, total RNA was
extracted with TRIzol (GIBCO BRL) and further reverse-
transcribed into cDNA with Ready-To-Go RT-PCR Beads (GE
Healthcare, Buckinghamshire, UK) and real-time PCR was
performed as described. For RNA polymerase III studies, Raw
264.7 cells were pretreated with the Pol-III inhibitor, ML-60218
(Calbiochem, Darmstadt, Germany), at 0.1 mM or 1.0 mM for
10 hours and then stimulated with 10
3 bacteria/cell, 1 mgo f
purified Brucella DNA, or 10 mg/mL of poly I:C (InvivoGen, San
Diego, CA) for 3 hours. The supernatants were collected and the
total RNA was extracted from the cells to access the expression of
IFN-b by real-time RT-PCR as described above.
Statistical analysis
The differences in IFN-b, IFN-c, IL-17 and NO levels between
wild type and IFN-abR KO mice were analyzed by Student’s t test
using two-tail distribution. The differences in the relative
expression of target genes were analyzed by Student’s t test, using
one tail distribution and heteroscedastic variance.
Supporting Information
Figure S1 Lack of type I IFN signaling is not related to
IL-17A production in Brucella-infected splenocytes.
Spleen cells from B. abortus S2308 infected 129Sv/Ev or IFN-
abR KO mice after two-weeks of infection were cultured with 10
2
bacteria/cell, ConA (5 mg/ml) or medium alone for 72 hrs and IL-
17A was detected by ELISA. Error bars represent the mean 6SD.
Similar results were obtained in two-independent experiments.
Statistically significant difference from medium alone compared to
bacteria or ConA is denoted by an asterisk (p,0.05).
(TIF)
Figure S2 Brucella DNA but not its LPS or lipidated-
Omp19 induces IFN-b expression in macrophages.
BMDM from C57BL/6, TLR2 or TLR4 KO mice were infected
with B. abortus strain S2308 (10
3 bact/cell), stimulated with Brucella
DNA (1 mg/5610
5 cells), Brucella DNA treated with DNAse
(0.2 U/mg DNA), poly I:C (10 mg/ml), Brucella LPS (10 mg/ml),
Brucella L-Omp19 (25 mg/ml) or medium alone. Twenty four
hours after stimulation of the cells, total RNA was harvested and
mRNA levels of IFN-b was determined by real-time RT-PCR and
normalized to b-actin. Error bars represent the mean 6SD of
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independent experiments. Statistically significant difference of
IFN-b levels from stimulated macrophages versus non-stimulated
cells is denoted by an asterisk and from Brucella DNA compared to
Brucella DNA treated with DNAse with two asterisks (p,0.05).
(TIF)
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